Research work · 2013
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell, Ian Chau, David Cunningham, David González de Castro, Alicia F. C. Okines, Andrew Charles Wotherspoon, Claire Saffery, Gary Middleton, Jonathan Wadsley, David Raymond Ferry, Wasat Mansoor, Tom David Lewis Crosby, Fareeda Y. Coxon, David A. B. Smith, Justin S. Waters, Timothy J. Iveson, Stephen J. Falk, Sarah Slater, Clare Peckitt, Yolanda Barbáchano
The Lancet Oncology